BHV-1 DNA vaccination: effect of the adjuvant RN-205 on the modulation of the immune response in mice (Q40729197)

23 September 2017

title

BHV-1 DNA vaccination: effect of the adjuvant RN-205 on the modulation of the immune response in mice (English)

1 reference

23 September 2017

Zamorano P

1

1 reference

23 September 2017

Taboga O

2

1 reference

23 September 2017

Domínguez M

3

1 reference

23 September 2017

Romera A

4

1 reference

23 September 2017

Puntel M

5

1 reference

23 September 2017

Tami C

6

1 reference

23 September 2017

Mongini C

7

1 reference

23 September 2017

Waldner C

8

1 reference

23 September 2017

Palma E

9

1 reference

23 September 2017

Sadir A

10

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

20

1 reference

23 September 2017

issue

21-22

1 reference

23 September 2017

page(s)

2656-2664

1 reference

Liposomes containing lipid A as a potent non-toxic adjuvant

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

The skin immune system: progress in cutaneous biology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Expression, purification, and characterization of the active immunoglobulin-like domain of human granulocyte-colony-stimulating factor receptor in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

DNA/genetic vaccination (minireview).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

1 reference

7 January 2021

Polynucleotide vaccines in animals: enhancing and modulating responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Nicotinamide and 3-Aminobenzamide Reduce Interferon-γ -Induced Class II MHC (HLA-DR and -DP) Molecule Expression on Cultured Human Endothelial Cells and Fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900211-6

7 January 2021

10.1016/S0264-410X(02)00211-6

Identifiers

DOI

1 reference

23 September 2017

1 reference